An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo

Pradip De, Nandini Dey, Breanne Terakedis, P. Leif Bergsagel, Zhi Hua Li, Daruka Mahadevan, Joseph R. Garlich, Suzanne Trudel, Milan T. Makale, Donald L. Durden

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint Dive into the research topics of 'An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds